TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy

Aim: We evaluated a novel approach combining the use of attenuated Salmonella immunotherapy with a Toll-like receptor agonist, imiquimod, in B16F1 melanoma-bearing mice. Materials & methods: B16F1 melanoma-bearing mice were daily treated with topical imiquimod in combination with one intratumoral in...

Full description

Bibliographic Details

Main Author:	Vola, Magdalena (author)
Other Authors:	Monaco, Amy (author), Bascuas, Thais (author), Rimsky, Geraldine (author), Agorio, Caroline Isabel (author), Chabalgoity, José Alejandro (author), Moreno, María (author)
Format:	article
Language:	English
Published:	2018
Subjects:	Experimental model Imiquimod Immunotherapy Melanoma Salmonella
Online Access:	https://hdl.handle.net/20.500.12008/42097
Tags:	Add Tag No Tags, Be the first to tag this record!